Nektar Therapeutics
NKTR
NKTR
137 hedge funds and large institutions have $85.3M invested in Nektar Therapeutics in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 47 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
32% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 47
52% less call options, than puts
Call options by funds: $23K | Put options by funds: $48K
Holders
137
Holding in Top 10
–
Calls
$23K
Puts
$48K
Top Buyers
| 1 | +$11.1M | |
| 2 | +$2.26M | |
| 3 | +$1.92M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.76M |
| 5 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$1.05M |
Top Sellers
| 1 | -$4.02M | |
| 2 | -$3.08M | |
| 3 | -$2.65M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.43M |
| 5 |
Millennium Management
New York
|
-$1.95M |